Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
2010 Commonwealth Games ~ 2010 Nobel Prizes ~ Sachin Tendulkar ~ Rajasthan Royals ~ Kings XI Punjab ~ Sushil Kumar ~ Deepika Kumari ~ Somdev Devvarman ~ HR Bhardwaj
Home / India News / 2007 / January / January 9, 2007
Competing in the U.S. Contract Research Market: What Pharma & Biotech Companies Want and How to Compete for their Business

Top News

144 Section in Hyderabad ahead of Ayodhya verdict

Manmohan Singh to campaign in Bihar today

FBI failed to act on Headley's wife's terror link expose 3 yrs before Mumbai attacks

Craven's horror flicks 'were inspired by real stories'

RBI will intervene if inflows turn lumpy: Subbarao

Enforcement Directorate issues 'Look Out Circular' against Lalit Modi

Now, laser technology that destroys tumours using heat

Waist size, not BMI can foretell cardiovascular risk in children

Competing in the U.S. Contract Research Market: What Pharma & Biotech Companies Want and How to Compete for their Business

Mumbai, Maharashtra, India

Frost & Sullivan's Healthcare Division will be releasing an end-user study on the increasingly competitive landscape of the CRO market. The study, entitled "Competing in the U.S. Contract Research Market: What Pharma & Biotech Companies Want and How to Compete for their Business" is the result of extensive interviews conducted across Pharmaceutical and Biotech companies, and provides insights on how CROs are evaluated within a scenario of tightening outsourcing budgets.

Outsourcing to CROs by pharmaceutical and biotechnology companies continues to be a growing trend with more than 20 percent of cardiovascular and oncology clinical development currently being outsourced. Additionally, therapeutic areas such as metabolic diseases are likely to be increasingly outsourced in the next 12-24 months.

If you are interested in a complimentary brochure, which provides an overview of this informative End-User Study on the CRO Market, please send an e-mail to Shwetha Thomas and Nimisha Iyer - Corporate Communications at / with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

Due to increased globalization of clinical trial activity, there is indication of a possible slight shift in clinical trial activities from North America to other regions. North America's share of clinical trials is expected to decrease from 61 percent to 53 percent in the next 3-5 years.

The primary reasons for outsourcing include a reduction in manpower required by pharmaceutical and biotech firms, greater geographic coverage provided by CROs, better access to patients for clinical trials and an enabling of R&D in non-core therapeutic areas.

Furthermore, there is some indication of a trend towards significant reductions in outsourcing / CRO budgets in the next 12 to 24 months for the majority of pharmaceutical and biotechnology companies surveyed. The source of this reduction appears to be an overall expectation of decline in outsourcing costs, most likely due to intensifying competition, rather from a decline in the rate of outsourcing itself.

Frost & Sullivan's comprehensive end-user study on the CRO Market will include the following elements:

-- Analysis of various Contract Research Organization (CRO) market segments: The study identifies and describes 3 market segments, derived statistically, in terms of their breadth, scope and intensity of outsourcing, perceived motives for outsourcing, and criteria for CRO selection.

-- Perceived strengths of the largest CROs: The study evaluates the perceived positioning of 11 large CROs, based on how they are associated with various key attributes.

-- Data and Information on Selection Criteria of CROs: This study encompasses vital feedback allowing CROs to gain insight into current and future outsourcing patterns and trends, to better understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements.

-- Varied sample of respondents: The sample includes representatives of both Pharmaceutical (65%) and Biotechnology Companies (35%). The 180 respondents were involved either in R&D, Clinical Development, Product Management, Purchasing, Quality Control, or Regulatory functions.

-- Proven survey methods: The study includes survey methods such as ANOVA, MaxDiff, Cluster Analysis, Factor Analysis, Correspondence Analysis, Multiple Regression, and Logistic Regression.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit

Shwetha Thomas, Corporate Communications - South Asia & Middle East, Frost & Sullivan, + 91 (022) 4001 3429

Nimisha Iyer, Corporate Communications - South Asia & Middle East, Frost & Sullivan, + 91 (022) 4001 3431

Source: Frost & Sullivan (Business Wire India)

Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.

India News / Press Releases on January 9, 2007

Significant Drop in Mobile User Satisfaction Levels in 2006: Voice&Data Nationwide Survey of 4,524 Mobile Users
Business Wire India

Promise of Five-Cent Tag Cheers Venture Capitalists in the World Radio Frequency Identification Market
Business Wire India

Competing in the U.S. Contract Research Market: What Pharma & Biotech Companies Want and How to Compete for their Business
Business Wire India

Kingfisher Airlines Launches Direct Flights Between Bangalore and Tiruchirapally
Business Wire India

Teledata Informatics Ltd. acquires 100% stake in Soltius Pte. Ltd, Singapore
Ad-Factors PR

Stock Settlement NSE completes its 1727th Normal Settlement
National Stock Exchange of India Limited

Stock Settlement News about Jai Corp Limited
National Stock Exchange of India Limited

Stock Settlement Corporates with highest number of complaints pending
National Stock Exchange of India Limited

Bombay Stock Exchange Deals reported on ICDM
Bombay Stock Exchange

Also see International News / Press Releases on January 9, 2007

Suggested pages for your additional reading on Facebook

© 2000-2017 All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us